Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international …

EJ Brenner, RC Ungaro, RB Gearry, GG Kaplan… - Gastroenterology, 2020 - Elsevier
Background and Aims The impact of Coronavirus disease 2019 (COVID-19) on patients with
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …

[HTML][HTML] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study

…, C Aloman, MJ Armstrong, E Pose, EJ Brenner… - Journal of …, 2021 - Elsevier
Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …

Effect of IBD medications on COVID-19 outcomes: results from an international registry

RC Ungaro, EJ Brenner, RB Gearry, GG Kaplan… - Gut, 2021 - gut.bmj.com
Objective We sought to evaluate COVID-19 clinical course in patients with IBD treated with
different medication classes and combinations. Design Surveillance Epidemiology of …

[HTML][HTML] Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

…, C Aloman, MJ Armstrong, EJ Brenner… - The lancet …, 2020 - thelancet.com
Background Despite concerns that patients with liver transplants might be at increased risk
of adverse outcomes from COVID-19 because of coexisting comorbidities and use of …

Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting

…, D Turner, MH Vatn, S Vermeire, EJ Brenner… - …, 2020 - gastrojournal.org
The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …

Z Izadi, EJ Brenner, SK Mahil, N Dand… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

Impact of medications on COVID-19 outcomes in inflammatory bowel disease: analysis of more than 6000 patients from an international registry

RC Ungaro, EJ Brenner, M Agrawal, X Zhang… - …, 2022 - gastrojournal.org
(SECURE-IBD) database, an international, collaborative database created to monitor COVID-19
outcomes in patients with inflammatory bowel disease (IBD), has previously reported …

Characteristics and outcomes of IBD patients with COVID-19 on tofacitinib therapy in the SECURE-IBD registry

M Agrawal, EJ Brenner, X Zhang… - Inflammatory bowel …, 2021 - academic.oup.com
METHODS The Surveillance Epidemiology of Coronavirus Under Research Exclusion for
Inflammatory Bowel Disease (SECURE-IBD) is a global, web-based, collaborative registry …

Inflammatory bowel disease clinical activity is associated with COVID-19 severity especially in younger patients

…, RC Ungaro, JF Colombel, EJ Brenner… - Journal of Crohn's …, 2022 - academic.oup.com
Background and Aims Age is a major prognostic factor for COVID-19 outcomes. The effect
of inflammatory bowel disease [IBD] activity on COVID-19 is unclear. We examined the …

Benign evolution of SARS-Cov2 infections in children with inflammatory bowel disease: results from two international databases

EJ Brenner, B Pigneur, G Focht, X Zhang… - Clinical …, 2021 - cghjournal.org
Methods The SECURE-IBD and the COVID-19 database of the Paediatric IBD Porto group
of the European Society for Paediatric Gastroenterology Hepatology and Nutrition were …